Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Modification and Selective Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of 1 2 3-O-triacetyl-5-deoxy-D-ribofuranose via patent CN102432642A. Delivers high purity, safety, and cost reduction in antitumor drug manufacturing.